OOIR: Observatory of International Research

Papers

(The TQCC of Cancer & Metabolism is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition	80
The classification of obesity based on metabolic status redefines the readmission of non-Hodgkin’s lymphoma—an observational study	58
A role of arginase-1-expressing myeloid cells in cachexia	38
GCN2-SLC7A11 axis coordinates autophagy, cell cycle and apoptosis and regulates cell growth in retinoblastoma upon arginine deprivation	34
FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinoma	34
Ketomimetic nutrients remodel the glycocalyx and trigger a metabolic defense in breast cancer cells	33
Lactate dehydrogenase A-coupled NAD+ regeneration is critical for acute myeloid leukemia cell survival	32
ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma	29
Cone photoreceptor phosphodiesterase PDE6H inhibition regulates cancer cell growth and metabolism, replicating the dark retina response	29
Autofluorescence imaging of endogenous metabolic cofactors in response to cytokine stimulation of classically activated macrophages	25
Correction: Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells	24
Circulating metabolome landscape in Lynch syndrome	22
Glycemic status, insulin resistance, and mortality from lung cancer among individuals with and without diabetes	20
Magnetospirillum magneticum triggers apoptotic pathways in human breast cancer cells	20
Identification and impact of microbiota-derived metabolites in ascites of ovarian and gastrointestinal cancer	19
Steatohepatitis-induced vascular niche alterations promote melanoma metastasis	19
Global metabolic alterations in colorectal cancer cells during irinotecan-induced DNA replication stress	19
ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors	18
Dexmedetomidine promotes colorectal cancer progression mediated by gamma-aminobutyric acid signaling	17
CYP19A1 regulates chemoresistance in colorectal cancer through modulation of estrogen biosynthesis and mitochondrial function	17
Characterizing OXPHOS inhibitor-mediated alleviation of hypoxia using high-throughput live cell-imaging	16
Disrupting Na+ ion homeostasis and Na+/K+ ATPase activity in breast cancer cells directly modulates glycolysis in vitro and in vivo	16
Effects of hyperinsulinemia on pancreatic cancer development and the immune microenvironment revealed through single-cell transcriptomics	15
Pharmacological inhibition of Peroxisome Proliferation-Activated Receptor Delta (PPARδ) imparts selective leukemia cell death	15
Long-acting Erwinia chrysanthemi, Pegcrisantaspase, induces alternate amino acid biosynthetic pathways in a preclinical model of pancreatic ductal adenocarcinoma	14

Correction: STEAP4 inhibits cisplatin-induced chemotherapy resistance through suppressing PI3K/AKT in hepatocellular carcinoma	14
BMP4 upregulates glycogen synthesis through the SMAD/SLC2A1 (GLUT1) signaling axis in hepatocellular carcinoma (HCC) cells	13
Pancreatic cancer tumor organoids exhibit subtype-specific differences in metabolic profiles	13
Comparative polar and lipid plasma metabolomics differentiate KSHV infection and disease states	13
Altered acetyl-CoA metabolism presents a new potential immunotherapy target in the obese lung microenvironment	12
Loss of hexokinase 1 sensitizes ovarian cancer to high-dose metformin	12
STEAP4 inhibits cisplatin-induced chemotherapy resistance through suppressing PI3K/AKT in hepatocellular carcinoma	12
Breast cancer cells that preferentially metastasize to lung or bone are more glycolytic, synthesize serine at greater rates, and consume less ATP and NADPH than parent MDA-MB-231 cells	12
Lactate metabolism in clonal plasma cells and its therapeutic implications in multiple myeloma patients with elevated serum LDH levels	12
Phosphoproteomics revealed cellular signals immediately responding to disruption of cancer amino acid homeostasis induced by inhibition of l-type amino acid transporter 1	12
Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation	11
Statin use as a moderator on the association between metformin and breast cancer risk in women with type 2 diabetes mellitus	11